Additional file 1: Table S1. of Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study
Number (percent) of bloodstream infection episodes stratified by microbe(s)/microbe group and by place of acquisition. Table S2. Number (percent) of bloodstream infection episodes stratified by microbe(s)/microbe group and by infection focus. Table S3. Proportions of bloodstream infection episodes with microbe(s) non-susceptible to four commonly used antibiotic regimens by place of acquisition. Table S4. Percent of bloodstream infection episodes with microbe(s) non-susceptible to commonly recommended sepsis regimens by site of infection. Table S5. Number of microbes not susceptible to penicillin-gentamicin-metronidazole by place of acquisition through three time periods. Table S6. Number of BSIs with Escherichia coli susceptible, intermediately susceptible or resistant to gentamicin through three time periods. Table S7. Number of BSIs with Escherichia coli non-susceptible to cefotaxime through three time periods. Table S8. Antimicrobial agents (single or in combinations) given as initial treatment in 1995 episodes of bloodstream infection. Table S9. Use of antibacterial agents and antineoplastic agents, measured in DDD/100 bed-days, at Levanger Hospital 2006 to 2013. Appendix 1 On inherent (natural) resistance in microbes. Rules for assessment of non-susceptibility in microbes not tested against antimicrobial agents in the laboratory. (DOCX 78 kb
